DocuSign Inc
Change company Symbol lookup
Select an option...
DOCU DocuSign Inc
VHUB Vapor Hub International Inc
VMC Vulcan Materials Co
VLO Valero Energy Corp
VIAC ViacomCBS Inc
VFC VF Corp
VECO Veeco Instruments Inc
VALE Vale SA
V Visa Inc
UVV Universal Corp
Go

Information Technology : Software | Large Cap Growth
Company profile

DocuSign Inc offers DocuSign Agreement Cloud, a software suite for automating the agreement process. It includes DocuSign eSignature, an electronic signature solution that allows an agreement to be signed electronically on a variety of devices. The Agreement Cloud also includes several other applications for automating pre- and post-signature processes, such as automatically generating an agreement from data in other systems, supporting negotiation workflow, collecting payment after signatures, and using artificial intelligence (AI) to analyze a collection of agreements for risks and opportunities. The Agreement Cloud also includes hundreds of integrations to other systems, so agreement processes can integrate with other business processes and data. Its key Agreement Cloud products include DocuSign Contract Lifecycle Management (CLM), Intelligent Insights, Gen for Salesforce, Negotiate for Salesforce, Guided Forms, Click, Identify, Standards-Based Signatures, Payments and eNotary.

Price
Delayed
$273.70
Day's Change
13.09 (5.02%)
Bid
--
Ask
--
B/A Size
--
Day's High
275.84
Day's Low
261.19
Volume
(Average)

Today's volume of 3,738,015 shares is on pace to be in-line with DOCU's 10-day average volume of 5,708,439 shares.

3,738,015

Tilray rated overweight at Cantor after Aphria merger closes

7:11 am ET June 4, 2021 (MarketWatch)
Print

Cantor Fitzgerald assigned Tilray Inc. (TLRY) an overweight rating this week and said the new company -- it recently closed its merger with Aphria Inc. -- is alone among Canadian licensed producers with domestic scale and a credible overseas platform. Analyst Pablo Zuanic assigned the stock a $22 price target that is down from $30.25 before the merger, but about 11.5% above its current trading level. "Except in recent months (deal-related distraction?), Aphria was one of the best performers in Canada recreational (cannabis) achieving a #1 position (speaking in organic terms, and did so while achieving positive cannabis EBITDA), and Tilray ran ahead of peers in the export cannabis markets," Zuanic wrote in a note to clients. "We do not see another LP that can make these combined claims." Questions do remain however, about how the combined entity will meet some of its guidance, including a 30% share of the Canadian recreational market and a C$100 million ($82.4 million) cost synergy target, he wrote. Cantor is expecting the Canadian sector to enjoy favorable headwinds in the months ahead as consumer demand recovers from COVID and assuming some U.S. deregulation. Tilray shares were up 0.7% premarket and have gained 139% in the year to date, while the Cannabis ETF (THCX) has gained 42% and the S&P 500 has gained 11.6%.

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

	

(END) Dow Jones Newswires

June 04, 2021 07:11 ET (11:11 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.